Form 4 Filing for DEXCOM INC (DXCM)

Kevin R. Sayer, Executive Chair of DEXCOM INC, reported a sale of 26,756 shares of Common Stock on July 20, 2026, under a 10b5-1 plan adopted on February 18, 2026. The weighted average sale price was $76.3193, with transactions occurring between $75.80 and $76.62. Following the sale, Mr. Sayer owns 328,970 shares. The reported shares include 106,972 unvested restricted stock units. This filing is a report of insider transactions, specifically a sale executed under a pre-arranged trading plan.